P3 Health Partners reported a gross margin of 22.26% and a net margin of -0.55% for the quarter ended Jun 2026. These financial ratios cover 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||
| Gross Margin | -4.01% | -3.29% | -12.05% | 2.82% | 0.74% | -2.63% | -4.25% | 5.46% | 8.15% | 3.17% | -6.00% | 1.66% | 3.69% | -10.99% | -10.67% | 0.32% | 1.25% | -7.11% | -10.72% | 22.26% | ||
| EBT Margin | -20.38% | -20.52% | -12.05% | -22.22% | -335.16% | -26.31% | -205.44% | -17.27% | -8.31% | -12.79% | -19.41% | -12.24% | -7.33% | -29.40% | -33.50% | -11.57% | -11.72% | -20.12% | -43.33% | 4.38% | ||
| EBIT Margin | -17.96% | -18.01% | -12.05% | -19.07% | -338.53% | -24.17% | -207.79% | -16.16% | -6.39% | -11.73% | -18.53% | -11.28% | -8.26% | -29.55% | -37.36% | -10.21% | -9.59% | -12.81% | -39.98% | 10.67% | ||
| EBITDA Margin | -17.96% | -18.01% | -12.05% | -18.85% | -338.31% | -23.89% | -207.56% | -15.96% | -6.21% | -11.56% | -18.38% | -11.15% | -8.11% | -29.38% | -37.18% | -10.04% | -9.42% | -12.66% | -39.85% | 10.67% | ||
| Operating Margin | -17.96% | -18.01% | -12.05% | -19.07% | -338.53% | -24.17% | -207.79% | -16.16% | -6.39% | -11.73% | -18.53% | -11.28% | -8.26% | -29.55% | -37.36% | -10.21% | -9.59% | -12.81% | -39.98% | 10.67% | ||
| Net Margin | -20.38% | -20.52% | -12.05% | -3.87% | -335.16% | -26.31% | -206.16% | -17.36% | -8.38% | -12.93% | -19.92% | -12.77% | -7.59% | -28.40% | -34.84% | -11.86% | -5.72% | -20.12% | -43.06% | -0.55% | ||
| FCF Margin | -15.38% | -4.36% | -10.47% | -17.01% | -8.80% | -12.36% | -8.30% | -8.85% | -2.77% | -4.52% | -5.16% | -2.68% | -6.26% | -15.45% | -12.81% | -4.71% | -3.83% | -4.41% | ||||
| Efficiency | ||||||||||||||||||||||
| Assets AverageAssets Avg. | 208.90M | 316.85M | 1,900.43M | 1,413.67M | 1,129.85M | 872.00M | 888.19M | 902.93M | 878.93M | 858.45M | 874.34M | 863.05M | 808.38M | 783.64M | 757.73M | 707.57M | 670.10M | 655.52M | ||||
| Invested CapitalInvested Cap. | 2.39M | 1.18M | 1.44M | 0.83M | 0.21M | 75.16M | 65.00M | 80.00M | 38.61M | 45.04M | 21.80M | |||||||||||
| Asset Utilization RatioAsset Util. | 0.48 | 0.71 | 0.93 | 1.24 | 1.28 | 1.30 | 1.44 | 1.58 | 1.60 | 1.71 | 1.86 | 1.90 | 1.93 | 2.04 | 2.18 | 2.25 | ||||||
| Leverage & Solvency | ||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -10.30 | -5.76 | -18.95 | -20.27 | -4.37 | -3.36 | -2.15 | -9.84 | 5.24 | |||||||||||||
| Debt Ratio | 0.03 | 0.06 | 0.06 | 0.11 | 0.12 | 0.12 | 0.12 | 0.13 | 0.14 | 0.15 | 0.16 | 0.23 | 0.30 | 0.36 | 0.43 | 0.48 | 0.22 | |||||
| Times Interest Earned | -10.30 | -5.76 | -18.95 | -20.27 | -4.37 | -3.36 | -2.15 | -9.84 | 5.24 | |||||||||||||
| Return Ratios | ||||||||||||||||||||||
| Return on Sales [ROS]ROS | 0.00% | 0.00% | 0.00% | 0.00% | -0.03% | 0.00% | -0.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Return on Capital Employed [ROCE]ROCE | -60.94% | -88.55% | -175.74% | -258.59% | -104.49% | -100.72% | -28.98% | -31.05% | -33.18% | -53.83% | -102.79% | -113.85% | -125.71% | -89.89% | -216.51% | -71.55% | ||||||
| Return on Invested Capital [ROIC]ROIC | -4.37% | -6.57% | -0.96% | -1.04% | -0.08% | -0.03% | -0.02% | -0.01% | -0.01% | -0.01% | ||||||||||||
| Return on Assets [ROA]ROA | 0.00% | 0.00% | -0.01% | -0.01% | -0.01% | -0.02% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |